|I'm heading straight for Big Pharma after|
I bust this guy's head open and break
out of this developmental league.
Credit: Ryan Wolf/Phoenix New Times
If smaller companies are like the minor leagues in baseball (where future talent is grown and developed over time) and assuming that there is a more-than-likely chance (unlike the minor leagues) that your experience will translate into a better-paying job in the future, then it's worth it.
If taking a job at a smaller startup or a CRO is more like joining an independent league American football team* (where the chances of joining the NFL are vanishingly small), then no, it's not worth it and we're just keeping our jobs because we want to keep doing chemistry.To which beloved commenter bbooooooya said:
...there is little transition from biotech to the big boys, though it does happen. The opposite transition seems more favored. A few years as a director or group leader at a big pharm makes it easier to slide into a VP role at a small biotech with, I assume, a jump in salary (at least while the company is around). I'm assuming non-executive salaries in big pharms tap out near $200K for group leaders, maybe a bit more for directors(but really don't know)?I assume that bbooooooya would probably stick to his now year-old statement.
Lower in the hierarchy, if Pfizer (and other big pharma companies) are going to stick to their designer/synthesizer motif, then I don't see why designers at small organizations can't become designers at large organizations. (Apart from the typical
I'm sure there's a pony in here somewhere. Readers, your thoughts?
*Or an independent wrestling league (as pictured?)